The World Health Organization has launched its first clinical trial to evaluate whether an antiviral drug can prevent infection among people exposed to the Bundibugyo strain of Ebola virus, as an ongoing outbreak in the Democratic Republic of Congo continues to challenge containment efforts. According to the WHO, the trial was initiated this week in […]
The World Health Organization has announced the launch of the first clinical trial designed to test whether an antiviral drug can prevent Ebola infection in people who have been exposed to the Bundibugyo strain of the virus in the Democratic Republic of Congo. The trial, which began on Tuesday, comes as the ongoing outbreak continues
Health authorities in the Democratic Republic of the Congo are expanding treatment capacity in Ituri province as they work to contain an Ebola outbreak caused by the Bundibugyo virus. Patient care infrastructure has been significantly reinforced in recent weeks to respond to the evolving demands of the epidemic, according to reports from the affected region.
DRC Scales Up Ebola Treatment Capacity in Ituri Province as Outbreak Spreads Read More »
A deadly Ebola outbreak in the Democratic Republic of Congo is spreading at an alarming pace, the World Health Organization has warned, even as authorities and international partners step up efforts to contain the virus. The UN health agency said on Friday that the situation is “evolving fast,” underscoring the urgent need for coordinated action.
DR Congo Ebola outbreak spreading rapidly, WHO warns Read More »
